|
|
2075 North 55th Street
Boulder, CO 80301 USA
phone:+1 303 4421926
fax:+1 303 9386413
|
|
| Symbol |
ROG.VX |
| Exchange |
SWX |
| Founded |
1896 |
| Employees |
|
|
|
| www.roche.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Diagnostic and therapeutic product development |
|
| Management |
| Dr. Severin Schwan, Chief Executive Officer Roche Group; Dr. Erich Hunziker, Chief Financial and IT Officer; Pascal Soriot Chief Operating Officer Pharmaceuticals; Daniel O'Day, Chief Operating Officer Diagnostics; Dr. Gottlieb A. Keller, General Counsel |
| |
|
|
|
|
|
|
|
| Keywords |
| oncological, spiegelmers, nonimmunogenic, rna-based therapies, diagnostics |
|
|
|
| Description |
|
As a research-focused healthcare company, Roche discovers, develops and provides innovative diagnostic and therapeutic products and services that deliver significant benefits to patients and healthcare professionals � from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. Areas of drug development include viral infections, metabolic, central nervous system disorders and inflammatory diseases. As leader in in-vitro diagnostics, Roche supplies a wide range of rapid, reliable instruments and tests for disease screening and diagnosis in laboratories, at the point of care, and for patient self-management. Additionally, Roche Applied Science supplies a broad array of instruments and highly specific reagents and test kits for use in the diverse research market. |
|
| Technology / Differentiation |
| Roche assesses emerging technologies and is quick to adopt the ones that can enhance the ability to select the right compounds for further development or that can be used to create new and better diagnostic tests. New technologies and areas of research are the basis for today's and tomorrows medicine. Some of these have emerged only recently. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
